gip/glp-1 agonist Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic Mechanisms of action of GLP-1

How effective physical activity in reducing liver steatosis and/or reversing liver fibrosis in children

Marketed as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

The SLEEVEPASS trial demonstrated that patients who were randomly assigned to either a laparoscopy sleeve gastrectomy or a laparoscopic Roux-en-Y gastric bypass maintained a 43.5% and 50.7% excess weight loss a decade after the procedure

Many flavoured yogurts, yogurt drinks, and sweetened dairy products contain added sugars that can outweigh the benefits of their protein content

These therapies are widely used in hospitals, specialty clinics, and outpatient settings, with growing applications in chronic weight management and cardiovascular risk reduction

Targeted agonist delivery to CNS GLP1-R expressing sites, PVT, NTS, VTA, NAcc, or PBN reduces food intake without the expression of pica, a proxy of visceral illness [704,716,740,741]